Table 1 Clinicopathological characteristics.
From: Ghrelin expression is associated with a favorable outcome in male breast cancer
Variable | n | % |
|---|---|---|
Age (years) | Median 73 (range 23–98) | |
Tumour size (mm) | Median 20 (range 4–100) | |
Tumour histology | ||
Ductal | 170 | 86.3 |
Lobular | 6 | 3.0 |
Other | 7 | 3.6 |
NA | 14 | 7.1 |
Histologic grade | ||
I | 15 | 7.6 |
II | 96 | 48.7 |
III | 81 | 41.1 |
NA | 5 | 2.5 |
ER | ||
Positive | 183 | 92.9 |
Negative | 9 | 4.6 |
NA | 5 | 2.5 |
PgR | ||
Positive | 152 | 77.2 |
Negative | 38 | 19.3 |
NA | 7 | 3.6 |
HER2 (IHC) | ||
0 | 122 | 61.9 |
1 | 41 | 20.8 |
2 | 19 | 9.6 |
3 | 3 | 1.5 |
NA | 12 | 6.1 |
Nodal status | ||
Positive | 77 | 39.1 |
Negative | 88 | 44.7 |
NA | 32 | 16.2 |
Vital status | ||
Alive | 73 | 37.1 |
Dead | 124 | 62.9 |
Dead from breast cancer | 41 | 33.1 |
Chemotherapy | ||
Yes | 21 | 10.7 |
No | 158 | 80.2 |
NA | 18 | 9.1 |
Endocrine therapy | ||
Yes | 119 | 60.4 |
No | 64 | 32.5 |
NA | 14 | 7.1 |
Radiotherapy | ||
Yes | 81 | 41.1 |
No | 98 | 49.7 |
NA | 18 | 9.1 |
